Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference (pages 2247–2251)
Michael B. Atkins, Ronald M. Bukowski, Bernard J. Escudier, Robert A. Figlin, Gary H. Hudes, William G. Kaelin Jr, W. Marston Linehan, David F. McDermott, James W. Mier, Ivan Pedrosa, Brian I. Rini, Sabina Signoretti, Jeffrey A. Sosman, Bin Tean Teh, Christopher G. Wood, Amado J. Zurita and Laura King
Version of Record online: 28 APR 2009 | DOI: 10.1002/cncr.24229
The Third Cambridge Conference on Innovations and Challenges in Renal Cancer was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease.